Dr. Robert W. Holloway, MD, FACOG, FACS, DHc

Expert Publications

• Treatment options for endometrial cancer: experience with topotecan.
• Workshop: options for therapy in ovarian cancer.
• The efficacy and safety of the cytobrush during pregnancy.
• Endometroid adenocarcinoma of the uterus with cardiac metastasis. A case report and six-year follow-up.
• Surgical aspects of cervical cancer.
• Surgical staging of uterine cancer: an analysis of perioperative morbidity.
• Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer.
• Robotic surgery in gynecology.
• Robotic-assisted hysterectomy for endometrial cancer compared with traditional laparoscopic and laparotomy approaches: a systematic review.
• Functional characterization of a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in experimental models.
• Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors.
• Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.

Clinical Trials

• Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG

Media Releases

Dr. Holloway stands out as a distinguished figure in Gynecologic Oncology internationally, bringing both expertise and leadership to the medical community in Orlando. As a board-certified Gynecologic Oncologist and the Medical Director of the Gynecologic Oncology Program at the AdventHealth Cancer Institute, he has played a pivotal role in advancing healthcare for women with complex gynecologic illnesses.  AdventHealth’s Gynecologic Oncology Program is one of the largest clinical and research services in the Southeast US, supporting a three-year gynecologic oncology training program for graduate OB/GYN physicians.

With a broad educational background beginning at the University of Illinois in Champaign-Urbana, he embarked on his medical academic journey at Vanderbilt University School of Medicine, a prestigious institution known for producing top-tier medical professionals. He further refined his skills through his OB/GYN residency at the University of Alabama at Birmingham, followed by a fellowship in Gynecologic Oncology at Lombardi Cancer Institute, Georgetown University in Washington, DC.

Distinguished as a Fellow of the American College of Surgeons, Dr. Holloway is board-certified in obstetrics and gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology (ABOG). In 2015 he was awarded an honorary Doctorate of Science degree from Pleven Medical University for his efforts over several years assisting the development of a robotic surgery training program in Bulgaria.  He has lectured extensively in Europe, Asia, and South America and demonstrated live surgical techniques in many countries.

Among his notable research interests, Dr Holloway focuses on robotic surgery and novel therapies for gynecologic cancers. His expertise in robotic surgery is recognized globally, with surgeons from around the world having attended his advanced training programs. Considered  a leader in the integration of innovative surgical techniques, he has validated several procedures using the daVinci robotic surgical platform including infrarenal lymphadenectomy and sentinel lymph node mapping for uterine malignancies. Dr Holloway’s other interests included clinical trial development in medical oncology.  Pivotal in the development of oncolytic viral therapy for treatment resistant ovarian cancer, he currently serves as national principal investigator for the phase III OnPrime clinical trial, the first oncolytic viral phase 3 trial in gynecologic oncology.   His CV contains over 250 scientific abstracts, book chapters, and peer-reviewed publications.

On a professional level, he is a Founding Member of the Florida Society of Gynecologic Oncology and the Society for Robotic Surgery. He is a longstanding member of the Society of Gynecologic Oncology and a previous member of the Board of Directors. His election into AGOS (American Gynecological and Obstetrical Society) is a testament to his esteemed reputation among his peers nationally as an educator, clinician, and scientific investigator.

Recommended Articles

• What Are Fraternal Twins?

  Fraternal twins definitionFraternal twins are commonly known as "non-identical twins" and can be simply defined as siblings who share the same womb but with different amniotic sacs and placentas. Biologically, they are said to be "dizygotic" meaning two different sperm cells fertilized two...

• Signs and Symptoms of Genital Herpes

  Genital herpes is a common sexually transmitted disease (STD). It is a disease that causes sores or blisters, especially on the genital areas. This STD is the result of type 2 herpes simplex virus, or HSV2. Sometimes genital herpes is the result of the strand of the herpes simplex virus that causes...

• What are the Symptoms and Treatment for Vaginal Yeast Infections?

  An infection in the vagina caused by yeast cells is very common among women, and is not considered a serious condition. Yeast cells are normally present in small numbers in the vaginal region, but due to certain triggers they can start multiplying, resulting in infection and inflammation. Yeast...

• What Causes Vaginitis?

  When the vagina’s lining gets inflamed, vaginitis may occur. This is because the vagina contains its own chemical balance, and it can easily be disturbed. Women and girls can get this condition regardless of their age. Causes of VaginitisVaginitis may develop as a result of many...

• What Is Toviaz?

  Generic Name: FesoterodineBrand Name: ToviazWhat is Toviaz?Toviaz is a medication for the treatment of spasms that occur in the bladder muscles. The generic name of Toviaz is fesoterodine. This drug is mostly used for the treatment of an overactive bladder and other accompanying symptoms such...

• Appendicitis During Pregnancy: Signs and Symptoms

  Appendicitis During Pregnancy: Signs and SymptomsAppendicitis is a condition which occurs in about 1 in 1000 pregnancies. While it is most common during first 2 trimesters, it can occur in the last trimester too. It’s often hard for the pregnant woman to identify the signs and symptoms of...